Testosterone Cypionate/ Anastrozole *gs* OIL recall: Sterility Concern
TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar
Why was Testosterone Cypionate/ Anastrozole *gs* OIL recalled?
Lack of sterility assurance.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: a)750851 BUD: 7/18/2022; b) 754549 BUD: 8/2/2022
- Product
- TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar
- Recalling firm
- Drug Depot, Inc., dba APS Pharmacy
- Quantity
- 73 vials
- Distribution
- Nationwide in the USA including Puerto Rico.
- Recall date
- April 6, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)